Ralph Bernard Arlinghaus

University Of Texas Md Anderson Can Ctr

$3,580,180

Attributed

$3,580,180

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $262.8K · FY2005–14

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$3,580,180 · 6

By mechanism

P30$1,426,986 · 1

P01$1,109,502 · 3

R01$753,114 · 1

T32$290,578 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Richard E. Champlin$5,988,814
Peter F Thall$4,683,294
James P Kehrer$2,295,435
Andrew P Feinberg$58,785,687
Hagop Kantarjian$4,345,422

Others in their field

Top investigators on “Biomedical Facility”

David Heimbrook · Leidos Biomedical Research, Inc.$269,207,281
Mark S Klempner · Tufts Medical Center$133,377,807
Joseph E Robertson · Oregon Health & Science University$129,896,064
Lee Hamm · Tulane University Of Louisiana$114,986,978
Peter Gordon Gillespie · Oregon Health And Science University$108,298,240
Jeffrey S Flier · Beth Israel Deaconess Medical Center$90,163,926

Research focus

Biomedical FacilityProtein SequenceProtein Tyrosine KinaseCell LineAntigensSynthetic PeptideOncoproteinsHigh Performance Liquid ChromatographyPeptide Chemical SynthesisProtein PurificationHematopoietic Stem CellsHuman TissueChronic Myelogenous LeukemiaChimeric ProteinsLeukemiaImmunoprecipitationDoctor Of PhilosophyBaseDrug ResistanceBone MarrowClinical TrialsBlast PhaseGleevecChronic Myeloid Leukemia